The Use of Cyproheptadine in Pediatric Feeding Disorders

Conditions: Pediatric Feeding Disorder, Chronic, Avoidant Restrictive Food Intake Disorder

Sex: All

Ages: 2 Years – 6 Years

Healthy volunteers: No

Phase: PHASE4

Enrollment: 18

Sponsor: University of Miami

Location: University of Miami Department of Pediatric Gastroenterology Miami Florida

Summary

The goal of this clinical trial is to learn if Cyproheptadine, an appetite stimulant, can improve eating habits in children with Pediatric Feeding Disorders. Pediatric Feeding Disorders is a broad term that describes disorders of eating-related behaviors that causes altered consumption of food and impairs physical or psychosocial health.

Eligibility Criteria

Inclusion Criteria: * Any patient aged 2-6 years of age who presents to Pediatric Gastroenterology Clinic with complaint of "poor weight gain, malnutrition, failure to thrive/weight faltering, picky eating, or feeding issues" who screens positive for a pediatric feeding disorder using the Child eating disorder questionnaire (CEBQ) * Age Range: 2-6 years * English or Spanish speaking Exclusion Criteria: * Patients who are tube fed * Patients who are overweight (BMI at 85th%tile or greater) * Patients who have active symptoms from a diagnosis of a GI disorder (Inflammatory Bowel Disease, Eosinophilic Esophagitis, Gastritis) * Patients actively undergoing behavioral feeding therapy

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06751290). StuddyBuddy aggregates publicly available trial information.